News

Published on 19 Mar 2024 on Simply Wall St. via Yahoo Finance

Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)


Article preview image

Key Insights

Using the 2 Stage Free Cash Flow to Equity, Standard BioTools fair value estimate is US$2.46Current share price of US$2.59 suggests Standard BioTools is potentially trading close to its fair valueWhen compared to theindustry average discount of -16%, Standard BioTools' competitors seem to be trading at a greater premium to fair value

How far off is Standard BioTools Inc. (NASDAQ:LAB) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.

NASDAQ.LAB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap...

If you would prefer discover what analysts are predicting in terms of future growth, do not miss...

Simply Wall St. · via Yahoo Finance 2 Jan 2025

Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market...

Despite a decline in overall revenue, Standard BioTools Inc (LAB) shows resilience with strong...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

Millennium Management LLC Acquires Shares in Standard BioTools Inc

On September 30, 2024, Millennium Management LLC, a prominent hedge fund, expanded its investment...

GuruFocus.com · via Yahoo Finance 22 Oct 2024

Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5?

We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at wh...

Insider Monkey · via Yahoo Finance 1 Oct 2024

Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript

Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript May 11, 2024 Standard BioToo...

Insider Monkey via Yahoo Finance 12 May 2024

Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Standard BioTools Inc.'s (NASDAQ:LAB) business as it...

Simply Wall St. via Yahoo Finance 16 Apr 2024

Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)?

Standard BioTools Inc. (NASDAQ:LAB), might not be a large cap stock, but it led the NASDAQGS gain...

Simply Wall St. via Yahoo Finance 2 Apr 2024

Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Standard BioTools fair value estimate is...

Simply Wall St. via Yahoo Finance 19 Mar 2024

Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript

Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript February 28, 2024 Standard B...

Insider Monkey via Yahoo Finance 5 Mar 2024

Earnings call: Standard BioTools reports growth and merger with SomaLogic

Standard BioTools, Inc. (ticker: SBT), in its latest earnings call, reported a 2023 revenue of $1...

Investing.com 1 Mar 2024